icon-folder.gif   Conference Reports for NATAP  
  EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria
Back grey_arrow_rt.gif
Genotypic Characterisation of Filibuvir Resistance in Patients Receiving Four Weeks Co-administration of Filibuvir with pegIFN/RBV(12 Week Analysis)
  Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
J Mori1, JL Hammond2, S Srinivasan2
S Jagannatha2, E Van der Ryst1
1Pfizer Global Research & Development, Sandwich, Kent, UK2Pfizer Global Research & Development, New London, CT, USA

Shi ST, et al. Antimicrob Agents Chemother2009;53:2544-2552